3737.HK · ZHONGZHIPHARM
Hong Kong · RS rating 62 · As of 2026-10-14
| Price | 0.69 HKD |
|---|---|
| 1-day change | -0.7% |
| RS rating (overall / 1M / 3M / 12M) | 62 / 64 / 67 / 69 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 44 / 9 |
| Industry group (rank) | Pharma & Biotech (30) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +24.7% |
| Market cap (USD) | $79.0M |